KARA CAIN: Open Payments
NPI 1548726482 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,915 in 250 payments from 22 companies in 2025. Trend: 2023 $524 · 2024 $3,773 · 2025 $4,915
Food & beverage: $4,915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 74 | $1,507 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $450 |
| Janssen Biotech, Inc. | 26 | $404 |
| GENZYME CORPORATION | 11 | $324 |
| Phathom Pharmaceuticals, Inc. | 10 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $255 |
| Ardelyx, Inc. | 16 | $241 |
| Gilead Sciences, Inc. | 9 | $229 |
| PFIZER INC. | 12 | $217 |
| Lilly USA, LLC | 12 | $206 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, XIFAXAN, VOQUEZNA, RINVOQ, IBSRELA, ENTYVIO.
Industry payments across SC — which companies pay providers there.
